Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
26 oct. 2023 06h45 HE
|
BioNTech SE
Lead formulations evaluated in the Phase 1/2 study demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains Safety profile of the mRNA-based combination vaccine...
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
24 juil. 2023 09h49 HE
|
GreenLight Biosciences
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced...
mRNA Vaccines and Therapeutics Market Size is projected to reach USD 58.92 billion by 2031, growing at a CAGR of 13.3%: Straits Research
08 juin 2023 11h00 HE
|
Straits Research
New York, United States, June 08, 2023 (GLOBE NEWSWIRE) -- mRNA-based therapeutics and vaccines permit the combination of desirable immunological properties. These are manufactured in the laboratory...
mRNA Vaccines And Therapeutics Global Market to Show Decline in Growth at a CAGR of ~-34% by 2028 | DelveInsight
23 mai 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, May 23, 2023 (GLOBE NEWSWIRE) -- mRNA Vaccines And Therapeutics Global Market to Show Decline in Growth at a CAGR of ~-34% by 2028 | DelveInsight The rising demand for protection...
Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients
23 mars 2023 07h55 HE
|
Evaxion Biotech
Evaxion’s AI technology has led to the identification of new viral targets for cancer immunotherapy This potentially enables treatment for patients with cold tumors, normally unresponsive to...
Evaxion and Pantherna announce promising preclinical mRNA vaccine data
08 févr. 2023 06h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark and HENNIGSDORF, Germany, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing...
mRNA therapeutics and mRNA vaccines market is anticipated to grow at a steady pace, till 2035, claims Roots Analysis
01 févr. 2023 10h30 HE
|
Roots Analysis
London, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “mRNA Therapeutics and mRNA Vaccines Market, 2022–2035” report to its list of offerings. The mRNA...
The mRNA synthesis and mRNA manufacturing market is projected to be worth USD 1.5 billion by 2035, claims Roots Analysis
26 janv. 2023 11h25 HE
|
Roots Analysis
London, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “mRNA Synthesis and mRNA Manufacturing Services Market (2nd Edition), 2022–2035” report to its list of...
Global mRNA Vaccines Market Size – Forecasts to 2028
10 janv. 2023 09h15 HE
|
Global Market Estimates
Brooklyn, New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global mRNA Vaccines Market is projected to grow at a CAGR...
Update on First BioNTainer for African-based mRNA Manufacturing Facility
21 déc. 2022 08h45 HE
|
BioNTech SE
MAINZ, GERMANY, December 21, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) reached the next milestone in the establishment of scalable mRNA vaccine production in Africa. The six ISO-sized shipping...